Image

Promoting Palliative Care for People With Heart Failure

Promoting Palliative Care for People With Heart Failure

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This project will develop and test a novel clinical decision support tool (CDS) that encourages timely referral to palliative care for people hospitalized with heart failure. This intervention will incorporate an existing, validated 1-year mortality risk model into a CDS to deliver prognostic information and evidence-based decision support at the point of care. Thus, this research may lead to improved care-concordant and goal-directed care for people with heart failure.

Description

Healthcare providers will encounter the tool during the routine care of their hospitalized patients. Patients randomized to the intervention arm will have providers who receive the tool and can complete one post-trial survey. High use providers will also have the opportunity to participate in a survey and 1 post-trial interview. Level 2 providers will participate in one interview.

Eligibility

Inclusion Criteria:

Healthcare providers must meet the following criteria:

  • Are an attending physician, fellow, or resident, advanced practice nurse, or physician associate
  • Has ordering privileges
  • Are members of one of the hospitals' admitting teams (e.g., hospitalist service, cardiology service)
  • Anticipate employment at one of the two study sites for the 15-month trial period.

Or

  • Palliative care team member
  • Hospital administrator/quality and safety personnel

Patients of providers enrolled in the study must meet the following criteria for heart failure during hospitalization:

  • Age 18 years of age or older
  • N-terminal pro-B-type natriuretic peptide values of \>500 pg/ml
  • Received intravenous diuretics within 24 hours of admission.

Exclusion Criteria:

  • Pregnant at the time of admission.

Study details
    Heart Failure
    Palliative Care

NCT06933875

Yale University

18 July 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.